11/25/2020, 4:49 PM (Source: TeleTrader)
more TeleTrader news

Moderna surges 6% after vaccine deal news

Shares of American biotechnology company Moderna soared more than 6% after the company announced that the European Commission approved the purchase of 80 million doses of its COVID-19 vaccine candidate.

According to the Massachusetts-based firm's statement, the delivery of its mRNA vaccine could start in the first three months of the following year, while the European Union reserved the right to acquire an additional contingent of the same number of jab doses.

Moderna's shares were up by 5.95% at 10:48 am ET, selling for $104.45.

Breaking the News / BU